Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetic acid otic solution is a topical antimicrobial and acidifying agent manufactured by Qatar Pharma for the treatment of superficial infections of the external auditory canal, such as otitis externa (swimmer's ear). The solution works by acidifying the ear canal, creating an environment that is unfavorable for the growth of susceptible bacteria and fungi. Qatar Pharma, a generic pharmaceutical manufacturer based in Doha, produces this formulation as part of its topical and disinfectant product line. It is administered as ear drops and serves as an adjunct to other antimicrobial therapies or as a standalone treatment for mild infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetic acid otic solution (Qatar Pharma).